* Information on COVID-19 vaccines is rapidly evolving, and this fact sheet could become outdated by the time you read it. For the most up to date information, please call MotherToBaby at 866-626-6847. This sheet talks about COVID-19 vaccines in pregnancy and while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider. What is COVID-19? COVID-19 (short for Coronavirus Disease 2019) is an illness caused by a virus (called …
The Baby Blog: Research
COVID-19
* Information on COVID-19 is rapidly evolving, and this fact sheet could become outdated by the time you read it. For the most up to date information, please call MotherToBaby at 866-626-6847. This sheet talks about having COVID-19 in pregnancy and while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider. What is COVID-19? COVID-19 (Coronavirus Disease 2019) is an illness caused by a virus. The virus (called SARS-CoV-2) …
Atopic Dermatitis | Eczema
This sheet is about having atopic dermatitis in a pregnancy or while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider. What is atopic dermatitis? Atopic dermatitis has also been called atopic eczema and sometimes just eczema, for short. Atopic dermatitis is a medical condition that can make the skin red and itchy. For most people, atopic dermatitis starts in childhood, but it can also start in adulthood. For some people, …
Tildrakizumab (Ilumya®)
This sheet is about exposure to tildrakizumab in pregnancy and while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider. What is tildrakizumab? Tildrakizumab is a medication used to treat moderate-to-severe plaque psoriasis. It has been sold under the brand name Ilumya®. For more information about psoriasis in pregnancy, please see the MotherToBaby fact sheet on psoriasis at …
Benralizumab (Fasenra®)
This sheet is about exposure to benralizumab in pregnancy and while breastfeeding. This information should not take the place of medical care and advice from your healthcare provider. What is benralizumab? Benralizumab is a monoclonal antibody that belongs to the group of medications known as ‘biologics’, used to treat patients with severe eosinophilic asthma. It is administered by an injection under the skin (subcutaneous) every 4 weeks for the first 3 doses, followed by once every 8 …
